Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $2.255B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 11,034,280 | $277M | 12.3% | $10.53 | +78.7% | SHS | G72800108 |
| XNCR | XENCOR INC | 4,900,306 | $211M | 9.4% | $34.08 | +39.0% | COM | 98401F105 |
| — | MORPHIC HLDG INC | 2,999,315 | $190M | 8.4% | $20.98 | — | COM | 61775R105 |
| ANAB | ANAPTYSBIO INC | 7,151,624 | $154M | 6.8% | $23.11 | +9.2% | COM | 032724106 |
| NUVB | NUVATION BIO INC | 13,247,017 | $138M | 6.1% | $11.18 | 0.0% | COM CL A | 67080N101 |
| RLAY | RELAY THERAPEUTICS INC | 3,429,363 | $119M | 5.3% | $38.48 | +12.8% | COM | 75943R102 |
| SPRY | SILVERBACK THERAPEUTICS INC | 2,533,635 | $111M | 4.9% | $33.40 | +41.7% | COM | 82835W108 |
| KURA | KURA ONCOLOGY INC | 3,692,637 | $104M | 4.6% | $22.14 | +42.9% | COM | 50127T109 |
| — | MIRATI THERAPEUTICS INC | 464,298 | $79.53M | 3.5% | $97.40 | — | COM | 60468T105 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,092,218 | $75.76M | 3.4% | $31.45 | +0.5% | COM | 68622P109 |
| STTK | SHATTUCK LABS INC | 2,458,259 | $71.88M | 3.2% | $32.14 | +30.7% | COM | 82024L103 |
| NRIX | NURIX THERAPEUTICS INC | 2,019,019 | $62.77M | 2.8% | $29.56 | +28.0% | COM | 67080M103 |
| RCUS | ARCUS BIOSCIENCES INC | 2,195,892 | $61.66M | 2.7% | $24.83 | +40.2% | COM | 03969F109 |
| — | SOLID BIOSCIENCES INC | 9,202,702 | $50.89M | 2.3% | $7.31 | — | COM | 83422E105 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,103,950 | $45.89M | 2.0% | $28.83 | -15.1% | COM | 05370A108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,224,175 | $39.79M | 1.8% | $32.43 | 0.0% | COM | 28036F105 |
| — | NEOLEUKIN THERAPEUTICS INC | 3,122,704 | $38.44M | 1.7% | $7.28 | — | COM | 64049K104 |
| — | ATRECA INC | 2,426,685 | $37.2M | 1.6% | $17.34 | — | CL A COM | 04965G109 |
| DSGN | DESIGN THERAPEUTICS INC | 1,137,940 | $34.02M | 1.5% | $31.14 | 0.0% | COM | 25056L103 |
| — | GRITSTONE ONCOLOGY INC | 3,421,287 | $32.26M | 1.4% | $3.94 | — | COM | 39868T105 |
| ACIU | AC IMMUNE SA | 3,648,163 | $27.76M | 1.2% | $5.79 | +23.2% | SHS | H00263105 |
| — | AKOUOS INC | 1,975,984 | $27.41M | 1.2% | $22.50 | — | COM | 00973J101 |
| OVID | OVID THERAPEUTICS INC | 6,082,200 | $24.45M | 1.1% | $3.32 | 0.0% | COM | 690469101 |
| ARVN | ARVINAS INC | 318,704 | $21.07M | 0.9% | $76.50 | 0.0% | COM | 04335A105 |
| — | CHINOOK THERAPEUTICS INC | 1,250,001 | $19.43M | 0.9% | $15.86 | — | COM | 16961L106 |
| ALEC | ALECTOR INC | 602,600 | $12.14M | 0.5% | $17.93 | 0.0% | COM | 014442107 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,115,721 | $11.94M | 0.5% | $15.09 | 0.0% | COM | 28617K101 |
| — | KRONOS BIO INC | 387,357 | $11.34M | 0.5% | $29.87 | — | COM | 50107A104 |
| — | APPLIED MOLECULAR TRANS INC | 239,443 | $10.54M | 0.5% | $25.14 | — | COM | 03824M109 |
| — | ALLOVIR INC | 447,012 | $10.46M | 0.5% | $27.50 | — | COM | 019818103 |
| — | NUVATION BIO INC | 963,333 | $10.07M | 0.4% | $10.45 | — | *W EXP 07/07/202 | 67080N119 |
| — | TRANSLATE BIO INC | 596,900 | $9.843M | 0.4% | $16.49 | — | COM | 89374L104 |
| — | BCTG ACQUISITION CORP | 800,000 | $8.896M | 0.4% | $10.36 | — | COM | 05492W103 |
| — | ITEOS THERAPEUTICS INC | 260,000 | $8.887M | 0.4% | $24.67 | — | COM | 46565G104 |
| — | ALPINE IMMUNE SCIENCES INC | 741,290 | $7.858M | 0.3% | $8.79 | — | COM | 02083G100 |
| — | SYROS PHARMACEUTICALS INC | 1,000,000 | $7.48M | 0.3% | $10.85 | — | COM | 87184Q107 |
| CCCC | C4 THERAPEUTICS INC | 200,000 | $7.398M | 0.3% | $29.00 | +37.2% | COM STK | 12529R107 |
| — | MAGENTA THERAPEUTICS INC | 556,354 | $6.587M | 0.3% | $11.84 | — | COM | 55910K108 |
| PRTA | PROTHENA CORP PLC | 250,000 | $6.28M | 0.3% | $10.53 | +78.7% | Call | G72800108 |
| — | LOGICBIO THERAPEUTICS INC | 688,700 | $5.014M | 0.2% | $7.63 | — | COM | 54142F102 |
| — | BOLT BIOTHERAPEUTICS INC | 150,000 | $4.937M | 0.2% | $32.91 | — | COM | 097702104 |
| — | JIYA ACQUISITION CORP | 500,000 | $4.92M | 0.2% | $10.30 | — | COM CL A | 47760M102 |
| — | CYCLERION THERAPEUTICS INC | 1,606,276 | $4.482M | 0.2% | $5.17 | — | COM | 23255M105 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.476M | 0.2% | $11.00 | — | ORD SHS | G4411D109 |
| — | NGM BIOPHARMACEUTICALS INC | 143,567 | $4.173M | 0.2% | $30.29 | — | COM | 62921N105 |
| KYMR | KYMERA THERAPEUTICS INC | 100,000 | $3.886M | 0.2% | $30.53 | +97.2% | COM | 501575104 |
| DYN | DYNE THERAPEUTICS INC | 215,000 | $3.339M | 0.1% | $21.96 | -11.9% | COM | 26818M108 |
| — | VINCERX PHARMA INC | 150,000 | $2.895M | 0.1% | $20.91 | — | *W EXP 12/24/202 | 92731L114 |
| — | AERPIO PHARMACEUTICALS INC | 2,072,782 | $2.674M | 0.1% | $1.29 | — | COM | 00810B105 |
| BCAB | BIOATLA INC | 50,000 | $2.542M | 0.1% | $33.43 | +53.3% | COM | 09077B104 |
| — | BCLS ACQUISITION CORP | 200,000 | $2.114M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| MLTX | HELIX ACQUISITION CORP | 200,000 | $2.04M | 0.1% | $11.37 | — | COM CL A | G4444C102 |
| — | FRAZIER LIFESCIENCES ACQU CO | 200,000 | $2.032M | 0.1% | $10.38 | — | UNIT 12/09/2025 | G3710A121 |
| — | 5 01 ACQUISITION CORP | 200,000 | $1.998M | 0.1% | $10.17 | — | COM CL A | 33836P105 |
| — | EUCRATES BIOMEDICAL ACQU COR | 200,000 | $1.996M | 0.1% | $9.98 | — | SHS | G3141W106 |
| — | CONSONANCE HFW ACQUISITION C | 200,000 | $1.952M | 0.1% | $10.47 | — | UNIT 99/99/9999 | G2445M129 |
| — | CODIAK BIOSCIENCES INC | 115,195 | $1.737M | 0.1% | $32.30 | — | COM | 192010106 |
| PMVP | PMV PHARMACEUTICALS INC | 50,000 | $1.645M | 0.1% | $36.80 | +7.1% | COM | 69353Y103 |
| — | ARYA SCIENCES ACQU CORP IV | 150,000 | $1.571M | 0.1% | $10.47 | — | CL A | G31659108 |
| — | REPARE THERAPEUTICS INC | 50,000 | $1.535M | 0.1% | $31.02 | — | COM | 760273102 |
| — | FS DEVELOPMENT CORP II | 150,000 | $1.494M | 0.1% | $9.96 | — | COM CL A | 30318F100 |
| MGTX | MEIRAGTX HLDGS PLC | 94,819 | $1.368M | 0.1% | $16.89 | -7.5% | COM | G59665102 |
| — | DEERFIELD HEALTHCARE TECH AC | 100,000 | $1.212M | 0.1% | $15.60 | — | *W EXP 07/16/202 | 244413118 |
| — | TURMERIC ACQUISITION CORP | 100,000 | $977K | 0.0% | $9.77 | — | CL A | G9127T108 |
| — | KINNATE BIOPHARMA INC | 25,000 | $779K | 0.0% | $39.80 | — | COM | 49705R105 |
| — | EUCRATES BIOMEDICAL ACQU COR | 66,666 | $665K | 0.0% | $9.98 | — | *W EXP 10/23/202 | G3141W122 |
| — | LIFESCI ACQUISITION II CORP | 56,500 | $573K | 0.0% | $10.67 | — | COM | 53229E103 |
| — | F-STAR THERAPEUTICS INC | 46,000 | $498K | 0.0% | $10.83 | — | COM | 30315R107 |
| — | OMEGA ALPHA SPAC | 50,000 | $495K | 0.0% | $9.90 | — | CL A | G6749V107 |
| — | METACRINE INC | 62,207 | $386K | 0.0% | $10.21 | — | COM | 59101E103 |
| — | TURMERIC ACQUISITION CORP | 33,333 | $326K | 0.0% | $9.78 | — | *W EXP 10/08/202 | G9127T124 |